Related Experiment Video
Updated: Jun 28, 2025

A Uniform Shear Assay for Human Platelet and Cell Surface Receptors via Cone-plate Viscometry
Published on: June 5, 2019
Severe Thrombocytopenia in Infective Endocarditis
Mayuri Patel1, Biplov Adhikari1, Amrit Devkota1
1Medstar Health Internal Medicine Residency Program, Baltimore, MD, USA.
Thrombocytopenia, a low platelet count, is common in infective endocarditis (IE) and indicates higher mortality risk. Prompt antibiotic treatment for bacterial IE can effectively improve platelet counts, even in severe cases.
Area of Science:
- Cardiology
- Hematology
- Infectious Diseases
Background:
- Bacterial infective endocarditis (IE) affects heart valves and can lead to systemic complications.
- Thrombocytopenia (low platelet count) occurs in 20-25% of IE patients and is linked to increased mortality.
- Platelets play a crucial role in IE pathogenesis and reflect the host's response to bacteremia.
Observation:
- A 40-year-old male with a history of injection drug use presented with IE and severe thrombocytopenia.
- The patient's platelet count was monitored closely upon admission.
Findings:
- Intravenous antibiotic therapy led to a dramatic improvement in the patient's platelet counts.
- No additional interventions like plasmapheresis or platelet transfusions were required.
Implications:
- Thrombocytopenia in IE is a significant prognostic indicator of poor outcomes.
- Effective antibiotic treatment for bacterial IE can resolve thrombocytopenia, highlighting the importance of early diagnosis and management.
- This case underscores the potential for conservative management of thrombocytopenia in IE with appropriate antimicrobial therapy.
More Related Videos
11:18Real-time Imaging of Heterotypic Platelet-neutrophil Interactions on the Activated Endothelium During Vascular Inflammation and Thrombus Formation in Live Mice
Published on: April 2, 2013
07:50An In Vitro Model of a Parallel-Plate Perfusion System to Study Bacterial Adherence to Graft Tissues
Published on: January 7, 2019
Related Concept Videos
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.